Literature DB >> 35786392

Genomic map of candidate human imprint control regions: the imprintome.

Dereje D Jima1,2, David A Skaar1,3,4, Antonio Planchart1,3,4, Alison Motsinger-Reif2,3,5, Sebnem E Cevik4, Sarah S Park4,6, Michael Cowley1,3,4, Fred Wright1,2, John House2,3,4,5, Andy Liu7, Randy L Jirtle1,3,4, Cathrine Hoyo1,3,4.   

Abstract

Imprinted genes - critical for growth, metabolism, and neuronal function - are expressed from one parental allele. Parent-of-origin-dependent CpG methylation regulates this expression at imprint control regions (ICRs). Since ICRs are established before tissue specification, these methylation marks are similar across cell types. Thus, they are attractive for investigating the developmental origins of adult diseases using accessible tissues, but remain unknown. We determined genome-wide candidate ICRs in humans by performing whole-genome bisulphite sequencing (WGBS) of DNA derived from the three germ layers and from gametes. We identified 1,488 hemi-methylated candidate ICRs, including 19 of 25 previously characterized ICRs (https://humanicr.org/). Gamete methylation approached 0% or 100% in 332 ICRs (178 paternally and 154 maternally methylated), supporting parent-of-origin-specific methylation, and 65% were in well-described CTCF-binding or DNaseI hypersensitive regions. This draft of the human imprintome will allow for the systematic determination of the role of early-acquired imprinting dysregulation in the pathogenesis of human diseases and developmental and behavioural disorders.

Entities:  

Keywords:  Epigenetics; foetal origins; genomic imprinting; imprint control regions; methylation; whole genome

Year:  2022        PMID: 35786392     DOI: 10.1080/15592294.2022.2091815

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  1 in total

Review 1.  Racial disparities in liver cancer: Evidence for a role of environmental contaminants and the epigenome.

Authors:  Adriana C Vidal; Cynthia A Moylan; Julius Wilder; Delores J Grant; Susan K Murphy; Cathrine Hoyo
Journal:  Front Oncol       Date:  2022-08-22       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.